TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Sell | S | 11.22 | 127,244 | 1,427,614 | 20,598 | 147.8 K to 20.6 K (-86.07 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 0.00 | 80,798 | 0 | 80,798 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 13,930 | 0 | 27,861 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 10.57 | 13,930 | 147,186 | 2,974 | 16.9 K to 3 K (-82.41 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 13,930 | 0 | 16,904 | 3 K to 16.9 K (+468.39 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | A | 0.00 | 285,171 | 0 | 285,171 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | M | 0.00 | 59,701 | 0 | 119,403 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Buy | M | 0.00 | 59,701 | 0 | 860,582 | 800.9 K to 860.6 K (+7.45 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | A | 0.00 | 95,057 | 0 | 95,057 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 15,920 | 0 | 31,841 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 15,920 | 0 | 147,842 | 131.9 K to 147.8 K (+12.07 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 12,935 | 0 | 25,870 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 10.58 | 12,935 | 136,909 | 0 | 12.9 K to 0 (-100.00 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Grant | A | 0.00 | 12,935 | 0 | 12,935 | 0 to 12.9 K |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 85,551 | 0 | 85,551 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 95,057 | 0 | 95,057 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 18,905 | 0 | 37,811 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.57 | 9,515 | 100,536 | 73,454 | 83 K to 73.5 K (-11.47 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 18,905 | 0 | 82,969 | 64.1 K to 83 K (+29.51 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | A | 0.00 | 90,304 | 0 | 90,304 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 11,940 | 0 | 23,880 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 10.58 | 6,183 | 65,443 | 55,048 | 61.2 K to 55 K (-10.10 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 11,940 | 0 | 61,231 | 49.3 K to 61.2 K (+24.22 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | A | 0.00 | 99,809 | 0 | 99,809 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 13,930 | 0 | 27,861 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 10.57 | 6,012 | 63,523 | 77,976 | 84 K to 78 K (-7.16 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 13,930 | 0 | 83,988 | 70.1 K to 84 K (+19.88 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | A | 0.00 | 90,304 | 0 | 90,304 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 15,920 | 0 | 31,841 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 10.58 | 7,513 | 79,521 | 20,280 | 27.8 K to 20.3 K (-27.03 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 15,920 | 0 | 27,793 | 11.9 K to 27.8 K (+134.09 %) |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 10.88 | 1,400 | 15,231 | 0 | 1.4 K to 0 (-100.00 %) |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Buy | M | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.82 | 50,000 | 540,890 | 64,064 | 114.1 K to 64.1 K (-43.84 %) |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 10.86 | 606 | 6,583 | 70,058 | 70.7 K to 70.1 K (-0.86 %) |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,400 | 0 | 70,664 | 69.3 K to 70.7 K (+2.02 %) |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 2,101 | 0 | 0 | |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 10.88 | 993 | 10,803 | 11,873 | 12.9 K to 11.9 K (-7.72 %) |
| Mar 04 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 2,101 | 0 | 12,866 | 10.8 K to 12.9 K (+19.52 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | M | 0.00 | 65,047 | 0 | 195,143 | |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Buy | M | 0.00 | 65,047 | 0 | 800,881 | 735.8 K to 800.9 K (+8.84 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 20,598 | 0 | 61,795 | |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 20,598 | 0 | 131,922 | 111.3 K to 131.9 K (+18.50 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 24,934 | 0 | 74,805 | |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 10.93 | 63,278 | 691,350 | 29,953 | 93.2 K to 30 K (-67.87 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 10.83 | 9,849 | 106,673 | 93,231 | 103.1 K to 93.2 K (-9.55 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 24,934 | 0 | 103,080 | 78.1 K to 103.1 K (+31.91 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 15,177 | 0 | 45,534 | |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 10.88 | 60,410 | 657,237 | 0 | 60.4 K to 0 (-100.00 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 10.85 | 15,177 | 164,684 | 60,410 | 75.6 K to 60.4 K (-20.08 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Buy | M | 0.00 | 15,177 | 0 | 75,587 | 60.4 K to 75.6 K (+25.12 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 18,430 | 0 | 55,290 | |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Buy | M | 0.00 | 18,430 | 0 | 18,430 | 0 to 18.4 K |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 17,346 | 0 | 52,038 | |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 10.83 | 7,486 | 81,079 | 69,264 | 76.8 K to 69.3 K (-9.75 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 17,346 | 0 | 76,750 | 59.4 K to 76.8 K (+29.20 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 20,598 | 0 | 61,795 | |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 10.85 | 20,598 | 223,507 | 10,765 | 31.4 K to 10.8 K (-65.68 %) |
| Mar 02 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 20,598 | 0 | 31,363 | 10.8 K to 31.4 K (+191.34 %) |